Teladoc Health (NYSE:TDOC) Reaches New 12-Month Low at $6.76

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s stock price reached a new 52-week low during trading on Wednesday . The stock traded as low as $6.76 and last traded at $6.82, with a volume of 3020868 shares traded. The stock had previously closed at $7.12.

Analysts Set New Price Targets

Several brokerages have issued reports on TDOC. Piper Sandler decreased their price target on shares of Teladoc Health from $25.00 to $10.00 and set an "overweight" rating for the company in a research report on Tuesday, August 6th. Oppenheimer lowered their target price on Teladoc Health from $21.00 to $17.00 and set an "outperform" rating for the company in a research report on Thursday, August 1st. Cantor Fitzgerald reiterated an "overweight" rating and issued a $10.00 price target on shares of Teladoc Health in a research report on Tuesday, August 20th. Deutsche Bank Aktiengesellschaft decreased their price target on Teladoc Health from $15.00 to $10.00 and set a "hold" rating for the company in a research note on Friday, August 2nd. Finally, DA Davidson reduced their target price on Teladoc Health from $12.00 to $8.00 and set a "neutral" rating on the stock in a report on Thursday, August 1st. Fourteen research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and an average price target of $12.44.

Teladoc Health Stock Performance

The company has a market capitalization of $1.17 billion, a price-to-earnings ratio of -4.86 and a beta of 0.93. The company has a 50 day moving average price of $8.61 and a 200 day moving average price of $12.02. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. The business had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. Equities research analysts predict that Teladoc Health, Inc. will post -0.7 earnings per share for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the company's stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the transaction, the insider now owns 33,667 shares in the company, valued at $274,049.38. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the business's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now directly owns 33,667 shares of the company's stock, valued at approximately $274,049.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Laizer Kornwasser sold 10,879 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $88,555.06. Following the completion of the sale, the chief executive officer now directly owns 99,929 shares of the company's stock, valued at $813,422.06. The disclosure for this sale can be found here. In the last 90 days, insiders sold 42,880 shares of company stock valued at $355,689. 0.95% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

Several institutional investors have recently made changes to their positions in TDOC. Rubric Capital Management LP purchased a new position in shares of Teladoc Health in the 2nd quarter worth approximately $45,267,000. Point72 Asset Management L.P. boosted its stake in Teladoc Health by 221.9% in the second quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider's stock valued at $51,865,000 after acquiring an additional 3,655,436 shares during the last quarter. Clearline Capital LP grew its position in shares of Teladoc Health by 395.6% during the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock valued at $42,682,000 after acquiring an additional 3,483,665 shares during the period. Vanguard Group Inc. grew its position in shares of Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock valued at $377,451,000 after acquiring an additional 1,855,480 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in shares of Teladoc Health by 25.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider's stock worth $82,636,000 after purchasing an additional 767,999 shares during the last quarter. Institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.